Prediction of Side Effects Using Comprehensive Similarity Measures
- Authors
- Seo S.; Lee T.; Kim M.-H.; Yoon Y.
- Issue Date
- Feb-2020
- Publisher
- Hindawi Limited
- Citation
- BioMed Research International, v.2020
- Journal Title
- BioMed Research International
- Volume
- 2020
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/26361
- DOI
- 10.1155/2020/1357630
- ISSN
- 2314-6133
- Abstract
- Identifying the potential side effects of drugs is crucial in clinical trials in the pharmaceutical industry. The existing side effect prediction methods mainly focus on the chemical and biological properties of drugs. This study proposes a method that uses diverse information such as drug-drug interactions from DrugBank, drug-drug interactions from network, single nucleotide polymorphisms, and side effect anatomical hierarchy as well as chemical structures, indications, and targets. The proposed method is based on the assumption that properties used in drug repositioning studies could be utilized to predict side effects because the phenotypic expression of a side effect is similar to that of the disease. The prediction results using the proposed method showed a 3.5% improvement in the area under the curve (AUC) over that obtained when only chemical, indication, and target features were used. The random forest model delivered outstanding results for all combinations of feature types. Finally, after identifying candidate side effects of drugs using the proposed method, the following four popular drugs were discussed: (1) dasatinib, (2) sitagliptin, (3) vorinostat, and (4) clonidine. © 2020 Sukyung Seo et al.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - IT융합대학 > 컴퓨터공학과 > 1. Journal Articles
- 약학대학 > 약학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/26361)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.